NEW YORK (
Emergent BioSolutions Incorporated
) is trading at unusually high volume Thursday with 922,034 shares changing hands. It is currently at 4.8 times its average daily volume and trading up $4.23 (+19.7%) at $25.67 as of 10:51 a.m. ET.
Emergent BioSolutions has a market cap of $733.6 million and is part of the
Emergent BioSolutions Inc., a biopharmaceutical company, focuses on the development, manufacture, and commercialization of vaccines and antibody therapeutics primarily in the United States, the United Kingdom, and Vietnam. The company operates in two segments, BioDefense and BioSciences.
TheStreet Ratings rates Emergent BioSolutions as a
. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. You can view the full
See all heavy volume stocks in our
or get investment ideas from our
Interested in other stocks that are rising on unusually high volume? Get free SMS text alerts sent to you when the action happens by texting
to 95370 or select from